MedKoo Cat#: 555923 | Name: QQN52061
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

QQN52061 is GPR34 receptor modulator, which can control function of GPR34 receptor (as antagonist or inverse agonist). QQN52061 was first reported in PCT Int. Appl. (2006), WO 2006088246. This product has no formal name at the moment. For the convenience of communication, a temporary code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/naming).

Chemical Structure

QQN52061
QQN52061
CAS# 907952-06-1

Theoretical Analysis

MedKoo Cat#: 555923

Name: QQN52061

CAS#: 907952-06-1

Chemical Formula: C31H26ClNO4

Exact Mass: 511.1550

Molecular Weight: 512.00

Elemental Analysis: C, 72.72; H, 5.12; Cl, 6.92; N, 2.74; O, 12.50

Price and Availability

Size Price Availability Quantity
100mg USD 1,650.00 2 Weeks
200mg USD 2,650.00 2 Weeks
500mg USD 3,950.00 2 Weeks
1g USD 4,950.00 2 Weeks
2g USD 7,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
QQN52061; QQN-52061; QQN 52061;
IUPAC/Chemical Name
N-[(2E)-3-(4'-Chloro[1,1'-biphenyl]-4-yl)-1-oxo-2-propen-1-yl]-O-(phenylmethyl)tyrosine
InChi Key
QPRREELAPZFVLQ-WDOJQBHRSA-N
InChi Code
InChI=1S/C31H26ClNO4/c32-27-15-13-26(14-16-27)25-11-6-22(7-12-25)10-19-30(34)33-29(31(35)36)20-23-8-17-28(18-9-23)37-21-24-4-2-1-3-5-24/h1-19,29H,20-21H2,(H,33,34)(H,35,36)/b19-10+/t29-/m0/s1
SMILES Code
O=C(O)[C@H](CC1=CC=C(OCC2=CC=CC=C2)C=C1)NC(/C=C/C3=CC=C(C4=CC=C(Cl)C=C4)C=C3)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
to be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
GPR34 receptor antagonist 2 (Compound D2) is a GPR34 receptor antagonist, which can be used for the study to immune diseases, inflammatory diseases, allergic diseases, respiratory diseases, urological diseases, cardiovascular diseases.
In vitro activity:
Endogenous ligands of GPR34, a G protein-coupled receptor, act on histamine-releasing activity on antigen- or concanavalin A- stimulated rat mast cells and synergize with nerve growth factor on rat mast cells. It is a lipid suchas lysophosphatidylserine havingthe activity of releasing histamine. GPR34 antagonists can be used, for example, for histamine release inhibitors, immune diseases, edema, hyperacidity, etc. Reference: Preparation of N-acyl-amino acid derivatives for controlling function of GPR34 receptor as antagonists or inverse agonists. https://patents.google.com/patent/WO2006088246A1/
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 50.0 97.66
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 512.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
Preparation of N-acyl-amino acid derivatives for controlling function of GPR34 receptor as antagonists or inverse agonists Quick View Other Sources By Ito, Fumio; Kimura, Eiji; Imai, Tomomi; Mori, Masaaki; Aramaki, Yoshio; Kohara, Yasuhisa; Sugo, Tsukasa; Hayase, Yoji; Kobayashi, Hiromi; Ogi, Kazuhiro From PCT Int. Appl. (2006), WO 2006088246 A1 20060824. | Language: Japanese, Database: CAPLUS
In vitro protocol:
Preparation of N-acyl-amino acid derivatives for controlling function of GPR34 receptor as antagonists or inverse agonists Quick View Other Sources By Ito, Fumio; Kimura, Eiji; Imai, Tomomi; Mori, Masaaki; Aramaki, Yoshio; Kohara, Yasuhisa; Sugo, Tsukasa; Hayase, Yoji; Kobayashi, Hiromi; Ogi, Kazuhiro From PCT Int. Appl. (2006), WO 2006088246 A1 20060824. | Language: Japanese, Database: CAPLUS
In vivo protocol:
TBD
Preparation of N-acyl-amino acid derivatives for controlling function of GPR34 receptor as antagonists or inverse agonists Quick View Other Sources By Ito, Fumio; Kimura, Eiji; Imai, Tomomi; Mori, Masaaki; Aramaki, Yoshio; Kohara, Yasuhisa; Sugo, Tsukasa; Hayase, Yoji; Kobayashi, Hiromi; Ogi, Kazuhiro From PCT Int. Appl. (2006), WO 2006088246 A1 20060824. | Language: Japanese, Database: CAPLUS